July 24, 2018

WATCH: HOPE-2 Duchenne Clinical Trial – Webinar Recording with Capricor

Capricor Therapeutics recently joined PPMD for a community webinar update to discuss the HOPE-2 trial. During the webinar, Capricor provided a background of CAP-1002 and its clinical development to date that has led to the…

Learn More

July 19, 2018

PPMD Hosts Largest Annual Conference — Presentations Available for Download!

Thank you to everyone who joined us in Scottsdale, AZ for the 2018 Annual Conference! While the extensive agenda, research presentations, break-out sessions, and interactions with industry leaders were all an incredible part of this…

Learn More

July 19, 2018

PPMD Partners with PLAE Shoes

PPMD is excited to announce a new partnership with PLAE Shoes, a leader in comfortable, stylish, hand-crafted shoes for adults and kids. PLAE is a brand many families have turned to in our community because…

Learn More

July 18, 2018

Hayes Mechanical Golf Outing Raises Over $130,000 in the Fight to End Duchenne

On June 19, 240 golfers and volunteers came out for the annual Hayes Mechanical Golf Outing in memory of Patrick and Bobby Chilcutt at the Harborside Golf Course in Chicago. The outing is a corporate…

Learn More

July 17, 2018

2018 Annual Conference Resource Round Up

PPMD’s 2018 Annual Conference Resource Fair Providers Each year we welcome specialized resource providers from around the country to interact with us at PPMD’s Annual Conference. We so appreciate the time and investment from all…

Learn More

July 16, 2018

15th Annual Jumping Jack Charity Golf Tournament Another Huge Success to Help End Duchenne

The 15th Annual Jumping Jack for Duchenne MD Golf Tournament, Wine Tasting, Dinner & Silent Auction that took place on June 18thin Westminster, CO was another huge success! The Knight Family has raised over $530,000 over…

Learn More

June 27, 2018

Summit Therapeutics Announces PhaseOut DMD Did Not Meet Primary Endpoint

We are disappointed to learn that Summit Therapeutics plc today announced that their PhaseOut DMD trial has not met its primary or secondary endpoints after 48 weeks of treatment of ezutromid in patients with Duchenne….

Learn More

June 26, 2018

Vamorolone (VBP15) Top Line Data Shows Improvements in Strength and Endurance in Boys with Duchenne

ReveraGen BioPharma, with the Cooperative International Neuromuscular Research Group (CINRG), conducted an international clinical trial of vamorolone at 11 CINRG sites in 6 countries (US, Canada, Australia, Israel, UK, and Sweden). ReveraGen reports that the…

Learn More

June 26, 2018

#PPMDConference: Live Stream the Latest Duchenne Research News and Updates

Research. There is a momentum in the Duchenne research pipeline, the likes of which we have never seen before. Join us at PPMD’s Annual Conference, Thursday, June 28 – Saturday, June 30 to find out…

Learn More

June 26, 2018

2018 #PPMDConference Live Stream: Care & Advocacy Updates You Won’t Want to Miss!

With PPMD’s Annual Conference quickly approaching, we wanted to make sure you are aware of the incredible care and advocacy content that will be covered while we are in Arizona this week! Care It’s at…

Learn More